Terumo Corporation has officially unveiled the K-Pack Embrace, a sophisticated new active safety needle designed to redefine standards for both pharmaceutical manufacturing and clinical safety. The innovative product, which features a unique rigid cap and case architecture, is engineered to streamline downstream co-packing processes while ensuring the integrity of the needle from the factory floor to the final point of patient care.
As the pharmaceutical industry continues to shift toward high-speed, automated production lines, the K-Pack Embrace offers a critical solution. Its compact, hard-shell case is specifically optimized for automated co-packing, allowing manufacturers to integrate the needle into complex assembly lines with greater ease. The design includes a color-coded, tamper-evident label that features a 2D barcode (UDI carrier), a critical inclusion that supports modern, automated in-line visual inspection requirements. This focus on process efficiency ensures that pharmaceutical partners can maintain high throughput without compromising product quality.
Beyond manufacturing advantages, the K-Pack Embrace is built with the clinical environment in mind. The needle, which utilizes Terumo’s proprietary T-Sharp technology, is available in both 1-inch (25mm) and 5/8-inch (16mm) lengths. It is fully compatible with all ISO 80369-7 male connectors, making it versatile for a range of subcutaneous (SC), intramuscular (IM), and intravenous (IV) applications.
A primary driver behind the development of the K-Pack Embrace is the urgent need to mitigate the risks associated with needle stick injuries—a persistent concern in healthcare settings. The needle features an integrated, hinged safety shield that can be activated with a single hand. To ensure the safety mechanism has been properly engaged, the device provides three distinct confirmation cues: audible, visual, and tactile. This multi-sensory feedback loop is designed to provide healthcare professionals with immediate assurance that the needle is safely secured after use, thereby protecting both the clinician and the patient.
“The K-Pack Embrace design simultaneously protects the healthcare professional, patient and product, all while making the efficiencies of automated co-packing available to our pharmaceutical customers,” said Marco Chiado Piat, President of the Pharmaceutical Solutions Division at Terumo. “This new active safety needle builds protection and safety into a single product that aligns with our goal of producing injectable drug delivery solutions that improve the lives of patients.”
By bridging the gap between high-volume manufacturing demands and the rigorous safety requirements of clinical practice, Terumo’s K-Pack Embrace marks a significant advancement in drug delivery hardware. As the global healthcare sector continues to prioritize automation and harm reduction, the introduction of this protective, integration-ready needle provides a robust new standard for the industry.
Disclaimer: This content is auto-generated for informational purposes only.
Source: Read Original News
